Defective lysosomal release of glycoprotein-derived sialic acid in fibroblasts from patients with sialic acid storage disease.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Biochemical Journal

• Publication date

  1988-02-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ2500261PMID 2451509PMCID PMC1148842
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Free N-acetylneuraminic acid in tissues in Salla disease and the enzymes involved in its metabolism.

  2005cited by this paper
• N-Acetylneuraminic acid storage disease

  2004cited by this paper
• Infantile Sialic Acid Storage Disease: The Fate of Biosynthetically Labeled N-Acetyl-(3H)-Neuraminic Acid in Cultured Human Fibroblasts

  1986cited by this paper
• Studies on the defect underlying the lysosomal storage of sialic acid in Salla disease. Lysosomal accumulation of sialic acid formed from N-acetyl-mannosamine or derived from low density lipoprotein in cultured mutant fibroblasts.

  1986cited by this paper
• Free N-acetylneuraminic acid (NANA) storage disorders: evidence for defective NANA transport across the lysosomal membrane

  1986cited by this paper
• N-acetylneuraminic acid accumulation in a buoyant lysosomal fraction of cultured fibroblasts from patients with infantile generalized N-acetylneuraminic acid storage disease.

  1986cited by this paper
• Studies of lysosomal sialic acid metabolism: retention of sialic acid by Salla disease lysosomes.

  1986cited by this paper
• Prenatal diagnosis and confirmation of infantile sialic acid storage disease

  1986cited by this paper
• Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease.

  1986cited by this paper
• Defect in vitamin B12 release from lysosomes: newly described inborn error of vitamin B12 metabolism.

  1985cited by this paper
• Familial lysosomal storage disease with generalized vacuolization and sialic aciduria. Sporadic Salla disease.

  1985cited by this paper
• Specificity studies on the oligosaccharide neuraminidase of human fibroblasts.

  1984cited by this paper
• N-acetylneuraminic acid and sialoglycoconjugate metabolism in fibroblasts from a patient with generalized N-acetylneuraminic acid storage disease.

  1983cited by this paper
• Sialic acid storage disease with sialuria: clinical and biochemical features in the severe infantile type.

  1983cited by this paper
• Sialic acids : chemistry, metabolism and function

  1982cited by this paper
• Infantile form of sialic acid storage disorder: Clinical, ultrastructural, and biochemical studies in two siblings

  1982cited by this paper
• Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis.

  1982cited by this paper
• Generalized N‐Acetylneuraminic Acid Storage Disease: Quantitation and Identification of the Monosaccharide Accumulating in Brain and Other Tissues

  1982cited by this paper
• Sialidosis: a review of human neuraminidase deficiency.

  1979cited by this paper
• "Salla disease": a new lysosomal storage disorder.

  1979cited by this paper
• Two species of lysosomal organelles in cultured human fibroblasts.

  1979cited by this paper
• Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation.

  1976cited by this paper
• Studies on the chemical and enzymatic modification of glycoproteins. A general method for the tritiation of sialic acid-containing glycoproteins.

  1971cited by this paper
• The Metabolic Basis of Inherited Disease

  1967cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Lack of significant ganglioside changes in Slc17a5 heterozygous mice: Relevance to FSASD and Parkinson's disease

  2025cites this paper
• Profiling glycosphingolipid changes in mouse and human cellular models of lysosomal free sialic acid storage disorder

  2025cites this paper
• Lysosomal free sialic acid storage disorder iPSC-derived neural cells display altered glycosphingolipid metabolism

  2025cites this paper
• Mini-Review Free Sialic Acid Storage Disorder: Progress and Promise.

  2021cites this paper
• Metachromatic leukodystrophy

  2018cites this paper
• Inhibition of the key enzyme of sialic acid biosynthesis by C6-Se modified N-acetylmannosamine analogs

  2016cites this paper
• A rapid method for the preparation of ultrapure, functional lysosomes using functionalized superparamagnetic iron oxide nanoparticles.

  2015cites this paper
• A Novel Approach to Decrease Sialic Acid Expression in Cells by a C-3-modified N-Acetylmannosamine*

  2014cites this paper
• Constitutive expression of a COOH-terminal leucine mutant of lysosome-associated membrane protein-1 causes its exclusive localization in low density intracellular vesicles.

  2014cites this paper
• Label-free mass spectrometry proteome quantification of human embryonic kidney cells following 24 hours of sialic acid overproduction

  2013cites this paper
• Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome.

  2012cites this paper
• Lysosomal Free Sialic Acid Storage Disorders: Salla Disease and ISSD

  2007cites this paper
• Engineering mammalian cell line to improve sialylation

  2005cites this paper
• Lec3 Chinese Hamster Ovary Mutants Lack UDP-N-acetylglucosamine 2-Epimerase Activity Because of Mutations in the Epimerase Domain of the Gne Gene*

  2003cites this paper
• Evidence for a sialic acid salvaging pathway in lepidopteran insect cells.

  2003influential citation
• Sialic Acid Storage Disease and Related Disorders

  2003cites this paper
• Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells.

  2001cites this paper
• UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation.

  1999cites this paper
• Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders

  1998cites this paper
• Chapter 1b Normal and pathological catabolism of glycoproteins: Catabolic pathways

  1996cites this paper
• Impairment of ganglioside metabolism in cultured fibroblasts from Salla patients.

  1996cites this paper
• Storage material from urine and tissues in the nephropathic phenotype of infantile sialic acid storage disease

  1992cites this paper
• Salla disease variant in a Dutch patient

  1992cites this paper
• Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides.

  1991cites this paper
• The transport systems of mammalian lysosomes.

  1991cites this paper
• Disorders of glycoprotein degradation

  1990cites this paper
• Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts.

  1989cites this paper
• Defective lysosomal egress of free sialic acid (N-acetylneuraminic acid) in fibroblasts of patients with infantile free sialic acid storage disease.

  1989cites this paper
• Characterization of a proton-driven carrier for sialic acid in the lysosomal membrane. Evidence for a group-specific transport system for acidic monosaccharides.

  1989cites this paper